A Single-Blind, Randomized, Placebo Controlled, Rising Single Dose, Safety, Tolerability, Pharmacokinetic Study and Open-label Food Effect Study of RBx 10017609 in Healthy Adult Male Human Volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2016
At a glance
- Drugs RBx 10017609 (Primary)
- Indications Obstructive airway disorders
- Focus Adverse reactions
- 04 Jul 2012 Actual end date (22 Apr 2009) added as reported by Clinical Trials Registry - India.
- 04 Jul 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 24 Jun 2009 New trial record